health Nirsevimab Outperforms Maternal Vaccine in Reducing Infant RSV Hospitalizations
A major French study finds nirsevimab significantly lowers RSV hospitalizations and severe outcomes in infants compared to maternal vaccination, offering new clinical guidance.
